BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2021
View Archived Issues
Positive topline data from pivotal phase III SKYLIGHT 1 and SKYLIGHT 2 studies of fezolinetant
Read More
Insmed reports phase I safety and PK data for treprostinil palmitil inhalation powder
Read More
First-in-human data from SAD and MAD studies of LTI-291 in healthy volunteers
Read More
MMP-14 is a potential marker of vestibular schwannomas
Read More
Valneva initiates further phase III study of chikungunya vaccine candidate VLA-1553
Read More
European Commission approves Heplisav B
Read More
Dosing begins in phase II trial of BBP-418 for limb girdle muscular dystrophy type 2i
Read More
Targeting AMPK-alpha prevents drug-induced hair cell loss and hearing loss
Read More
Study links antidepressant action to TRKB binding
Read More
China NMPA grants conditional approval to toripalimab in nasopharyngeal carcinoma
Read More
Puppet masters of the human gut
Read More
Metabolic changes are antibiotic resistance mechanism
Read More
PTGER4 as new therapeutic target to promote intestinal macrophage healing in IBD
Read More
AUT-00206 ameliorates audition symptoms tied to schizophrenia
Read More
Ascletis reports data on ASC-41 in overweight and obese subjects
Read More
Immunicum reports updated phase II data on ilixadencel in metastatic renal cell carcinoma
Read More
Bionomics reports PK data on new solid dose oral tablet formulation of BNC-210
Read More
Sanofi and GSK study adjuvanted recombinant protein-based COVID-19 vaccine candidate in phase II
Read More
DSMC recommends continuation of phase III study of VB-111 for recurrent ovarian cancer
Read More
MediWound outlines clinical development plans for MWPC-005 in nonmelanoma skin cancer
Read More
